Name: Reviews on new Drug Targets in Age-Related Disorders (Advances in Experimental Medicine and Biology) (en Inglés)
Price: 294290.00 CLP
Availability: InStock
ISBN: 9783030426668

portada Reviews on new Drug Targets in Age-Related Disorders (Advances in Experimental Medicine and Biology) (en Inglés)

Formato

Libro Físico

Editorial

Springer

Año

1179

Idioma

Inglés

N° páginas

340

Encuadernación

Tapa Dura

ISBN13

9783030426668

N° edición

Categorías

Farmacia y prescripción

Reviews on new Drug Targets in Age-Related Disorders (Advances in Experimental Medicine and Biology) (en Inglés)

Libro Nuevo

$ 294.290

$ 408.740

Ahorras: $ 114.450

28% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Lunes 06 de Mayo y el Miércoles 15 de Mayo.

Lo recibirás en cualquier lugar de Chile entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Reviews on new Drug Targets in Age-Related Disorders (Advances in Experimental Medicine and Biology) (en Inglés)"

Aging is an inevitable part of life and is becoming a worldwide social, economic and health problem. This is mainly due to the fact that the increasing proportion of individuals in the advanced age category have a higher probability of developing age-related disorders, such as type II diabetes mellitus, cardiovascular disorders, sarcopenia, and neurodegenerative conditions. New therapeutic approaches are still needed to decrease or slow the effects of such diseases. Advances in -omic technologies, such as genomics, transcriptomics, proteomics and metabolomics, have significantly advanced our understanding of disease in multiple medical areas, as the analysis of multiple molecular networks has simultaneously provided a more integrated view of disease pathways. It is hoped that emerging hits from these analyses might be prioritized for further screening as potential novel drug targets for increasing the human healthspan in line with the lifespan. In turn, this will lead to new therapeutic strategies as well as drug development projects by the pharmaceutical industry. This book presents a series of reviews describing studies that have resulted in identification of new potential drug targets for age-related disorders. Much of this information has come from -omic comparisons of healthy and disease states or from testing the effects of new therapeutic approaches. Authored by experts from around the globe, each chapter is presented in the context of specific chronic diseases or therapeutic strategies. This book is designed for researchers in the areas of aging and chronic disease, as well as clinical scientists, physicians and stakeholders in major drug companies.